Apolipoprotein CIII polymorphism and triglyceride levels of a Japanese population living in Southern Brazil

Brazilian Journal of Medical and Biological Research

Volumn 41, Issue 6, 2008, Pages 462-467

  Parzianello, L ^a,b   Oliveira, G ^c   Coelho, J C ^a,d  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b Laboratório Parzianello   (Brazil)

^c PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^d HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Apolipoprotein Clll; Japanese population; SstI polymorphism; Triglycerides

Indexed keywords

APOLIPOPROTEIN C3; CHOLESTEROL; CYSTEINE; GENOMIC DNA; GLUCOSE; GLYCINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RESTRICTION ENDONUCLEASE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ALLELE; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANALYSIS OF VARIANCE; ARTICLE; BRAZIL; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DNA DETERMINATION; ENZYME ANALYSIS; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; HYPERTRIGLYCERIDEMIA; JAPANESE; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; ALLELES; APOLIPOPROTEIN C-III; ASIAN CONTINENTAL ANCESTRY GROUP; BRAZIL; CORONARY ARTERY DISEASE; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; JAPAN; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; TRIGLYCERIDES;

EID: 54749143201     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2008005000022     Document Type: Article

References (33)

1. Wu LL. Review of risk factors for cardiovascular diseases. Ann Clin Lab Sci 1999; 29: 127-133.
2. Parzianello L, Parzianello NA, Coelho JC. Increased triglyceride levels in a Japanese population living in southern Brazil. Arch Med Res 2005; 36: 59-64.
3. Russo GT, Meigs JB, Cupples LA, Demissie S, Otvos JD, Wilson PW, et al. Association of the Sst-I polymorphism at the APOC3 gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: the Framingham offspring study. Atherosclerosis 2001; 158: 173-181.
4. Waterworth DM, Talmud PJ, Bujac SR, Fisher RM, Miller GJ, Humphries SE. Contribution of apolipoprotein C-III gene variants to determination of triglyceride levels and interaction with smoking in middle-aged men. Arterioscler Thromb Vasc Biol 2000; 20: 2663-2669.
5. Jong MC, Hofker MH, Havekes LM. Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3. Arterioscler Thromb Vasc Biol 1999; 19: 472-484.
6. Ito Y, Azrolan N, O'Connell A, Walsh A, Breslow JL. Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice. Science 1990; 249: 790-793.
7. Maeda N, Li H, Lee D, Oliver P, Quarfordt SH, Osada J. Targeted disruption of the apolipoprotein C-III gene in mice results in hypotriglyceridemia and protection from postprandial hypertriglyceridemia. J Biol Chem 1994; 269: 23610-23616.
8. Talmud PJ, Humphries SE. Apolipoprotein C-III gene variation and dyslipidaemia. Curr Opin Lipidol 1997; 8: 154-158.
9. Rees A, Stocks J, Sharpe CR, Vella MA, Shoulders CC, Katz J, et al. Deoxyribonucleic acid polymorphism in the apolipoprotein A-1-C-III gene cluster. Association with hypertriglyceridemia. J Clin Invest 1985; 76: 1090-1095.
10. Tas S. Strong association of a single nucleotide substitution in the 3′-untranslated region of the apolipoprotein-CIII gene with common hypertriglyceridemia in Arabs. Clin Chem 1989; 35: 256-259.
11. Rees A, Stocks J, Paul H, Ohuchi Y, Galton D. Haplotypes identified by DNA polymorphisms at the apolipoprotein A-1 and C-III loci and hypertriglyceridaemia. A study in a Japanese population. Hum Genet 1986; 72: 168-171.
12. Tas S, Abdella NA. Blood pressure, coronary artery disease, and glycaemic control in type 2 diabetes mellitus: relation to apolipoprotein-CIII gene polymorphism. Lancet 1994; 343: 1194-1195.
13. Hong SH, Park WH, Lee CC, Song JH, Kim JQ. Association between genetic variations of apo AI-CIII-AIV cluster gene and hypertriglyceridemic subjects. Clin Chem 1997; 43: 13-17.
14. Surguchov AP, Page GP, Smith L, Patsch W, Boerwinkle E. Polymorphic markers in apolipoprotein C-III gene flanking regions and hypertriglyceridemia. Arterioscler Thromb Vasc Biol 1996; 16: 941-947.
15. Tybjaerg-Hansen A, Nordestgaard BG, Gerdes LU, Faergeman O, Humphries SE. Genetic markers in the apo AI-CIII-AIV gene cluster for combined hyperlipidemia, hypertriglyceridemia, and predisposition to atherosclerosis. Atherosclerosis 1993; 100: 157-169.
16. Ko YL, Ko YS, Wu SM, Teng MS, Chen FR, Hsu TS, et al. Interaction between obesity and genetic polymorphisms in the apolipoprotein CIII gene and lipoprotein lipase gene on the risk of hypertriglyceridemia in Chinese. Hum Genet 1997; 100: 327-333.
17. Ahn YI, Valdez R, Reddy AP, Cole SA, Weiss KM, Ferrell RE. DNA polymorphisms of the apolipoprotein AI/CIII/AIV gene cluster influence plasma cholesterol and triglyceride levels in the Mayans of the Yucatan Peninsula, Mexico. Hum Hered 1991; 41: 281-289.
18. Bai H, Saku K, Liu R, Imamura M, Arakawa K. Association between coronary heart disease and the apolipoprotein A-I/C-III/A-IV complex in a Japanese population. Hum Genet 1995; 95: 102-104.
19. Dammerman M, Sandkuijl LA, Halaas JL, Chung W, Breslow JL. An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3′ untranslated region polymorphisms. Proc Natl Acad Sci U S A 1993; 90: 4562-4566.
20. Chhabra S, Narang R, Krishnan LR, Vasisht S, Agarwal DP, Srivastava LM, et al. Apolipoprotein C3 Sst I polymorphism and triglyceride levels in Asian Indians. BMC Genet 2002; 3: 9.
21. Rees A, Shoulders CC, Stocks J, Galton DJ, Baralle FE. DNA polymorphism adjacent to human apoprotein A-1 gene: relation to hypertriglyceridaemia. Lancet 1983; 1: 444-446.
22. Hoffer MJ, Sijbrands EJ, De Man FH, Havekes LM, Smelt AH, Frants RR. Increased risk for endogenous hypertriglyceridaemia is associated with an apolipoprotein C3 haplotype specified by the SstI polymorphism. Eur J Clin Invest 1998; 28: 807-812.
23. O'Connor G, Stocks J, Lumley J, Galton DJ. A DNA polymorphism of the apolipoprotein C-III gene in extracoronary atherosclerosis. Clin Sci 1988; 74: 289-292.
24. Price WH, Morris SW, Kitchin AH, Wenham PR, Burgon PR, Donald PM. DNA restriction fragment length polymorphisms as markers of familial coronary heart disease. Lancet 1989; 1: 1407-1411.
25. Dallinga-Thie GM, Bu XD, van Linde-Sibenius TM, Rotter JI, Lusis AJ, de Bruin TW. Apolipoprotein A-I/C-III/A-IV gene cluster in familial combined hyperlipidemia: effects on LDL-cholesterol and apolipoproteins B and C-III. J Lipid Res 1996; 37: 136-147.
26. Dallinga-Thie GM, van Linde-Sibenius TM, Rotter JI, Cantor RM, Bu X, Lusis AJ, et al. Complex genetic contribution of the Apo AI-CIII-AIV gene cluster to familial combined hyperlipidemia. Identification of different susceptibility haplotypes. J Clin Invest 1997; 99: 953-961.
27. Shoulders CC, Grantham TT, North JD, Gaspardone A, Tomai F, De Fazio A, et al. Hypertriglyceridemia and the apolipoprotein CIII gene locus: lack of association with the variant insulin response element in Italian school children. Hum Genet 1996; 98: 557-566.
28. Shoulders CC, Harry PJ, Lagrost L, White SE, Shah NF, North JD, et al. Variation at the apo AI/CIII/AIV gene complex is associated with elevated plasma levels of apo CIII. Atherosclerosis 1991; 87: 239-247.
29. Shelburne F, Hanks J, Meyers W, Quarfordt S. Effect of apoproteins on hepatic uptake of triglyceride emulsions in the rat. J Clin Invest 1980; 65: 652-658.
30. Windler E, Havel RJ. Inhibitory effects of C apolipoproteins from rats and humans on the uptake of triglyceride-rich lipoproteins and their remnants by the perfused rat liver. J Lipid Res 1985; 26: 556-565.
31. Ginsberg HN, Le NA, Goldberg IJ, Gibson JC, Rubinstein A, Wang-Iverson P, et al. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo. J Clin Invest 1986; 78: 1287-1295.
32. Aalto-Setala K, Fisher EA, Chen X, Chajek-Shaul T, Hayek T, Zechner R, et al. Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles. J Clin Invest 1992; 90: 1889-1900.
33. Huang MC, Wang TN, Liu YL, Pa TH, Tu HP, Huang YC, et al. Effect of SstI polymorphism of the apolipoprotein CIII gene and environmental factors on risks of hypertriglyceridemia in Taiwan aborigines. Circ J 2006; 70: 1030-1036.